Cannell & Co. - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 39 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cannell & Co. ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2015$52,000
+6.1%
90,0000.0%0.00%
+100.0%
Q2 2015$49,00090,0000.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q3 2015
NameSharesValueWeighting ↓
HOME FEDERAL BANK OF TENNESSEE 100,000$8,5000.00%
LEE DANNER & BASS INC 50,000$40.00%
LBMC INVESTMENT ADVISORS, LLC 22,000$1,7160.00%
Atlas Wealth LLC 26,620$2,2490.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$1,6900.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders